Co-Diagnostics

+$0.53 (+10.66%) Today

+$0.02 (+0.36%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Co-Diagnostics and other ETFs, options, and stocks.

About CODX

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.

CEO

Dwight Howard Egan

Employees

101

Headquarters

Salt Lake City, Utah

Founded

2013

CODX Key Statistics

Market cap

Price-Earnings ratio

3.82

Dividend yield

—

Average volume

537.63K

High today

$5.89

Low today

$4.95

Open price

$4.99

Volume

2.77M

52 Week high

$11.82

52 Week low

$3.66

CODX News

MarketWatchMay 26

Co-Diagnostics Shares Rise 10% After Completing Principal Design of Test for Monkeypox Virus - MarketWatch

By Chris Wack Co-Diagnostics Inc. shares were up 10% to $5.07 after the company said it has completed the principal design work of a PCR test for the monkeypox

CODX Earnings

$0.00

$0.21

$0.42

$0.63

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

— per share

Actual

Expected Aug 11, After Hours